Journal of Personalized Medicine | |
Trends in Personalized Therapies in Oncology: The (Venture) Capitalist’s Perspective | |
Roman Fleck1  | |
关键词: global industry trends; collaboration BioPharma–Academia; oncology drug development; translational research; | |
DOI : 10.3390/jpm2010015 | |
来源: mdpi | |
【 摘 要 】
Oncology is one of the most important fields of personalized medicine as a majority of efforts in this field have recently centered on targeted cancer drug development. New tools are continuously being developed that promise to make cancer treatment more efficacious while causing fewer side effects. Like most industries, the biopharmaceutical industry is also following certain global trends and these are analyzed in this article. As academia and industry are mutually dependent on each other, researchers in the field should be aware of those trends and the immediate consequences for their research. It is important for the future of this field that there is a healthy relationship among all interested parties as the challenges of personalized medicine are becoming ever more complex.
【 授权许可】
CC BY
© 2012 by the authors; licensee MDPI, Basel, Switzerland.
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO202003190045654ZK.pdf | 323KB | download |